Horwitz, Steven ;
O'Connor, Owen A ;
Pro, Barbara...
Horwitz , S , O'Connor , O A , Pro , B , Illidge , T , Fanale , M , Advani , R , Bartlett , N L , Christensen , J H , Morschhauser , F , Domingo-Domenech , E , Rossi , G , Kim , W S , Feldman , T , Lennard , A , Belada , D , Illés , Á , Tobinai , K , Tsukasaki , K , Yeh , S-P , Shustov , A , Hüttmann , A , Savage , K J , Yuen , S , Iyer , S , Zinzani , P L , Hua , Z , Little , M , Rao , S , Woolery , J , Manley , T , Trümper , L & ECHELON-2 Study Group 2019 , ' Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial ' , Lancet , vol. 393 , no. 10168 , pp. 229-240 . https://doi.org/10.1016/S0140-6736(18)32984-2.
,
2019
